The Bone and Heart Risks Nobody Mentions at Menopause

The Bone And Heart Risks Nobody Mentions At Menopause

Most menopause conversations start with hot flashes, sleep, and mood; the symptoms you can feel. Two of the bigger changes happening underneath all of that get almost no airtime because they don't come with a symptom you notice in the moment:

What's happening to your bones
What's happening to your heart

The Bone Side

Estrogen plays a direct role in maintaining bone density, and its decline during menopause accelerates bone loss noticeably, enough that osteoporosis risk rises sharply in the years following the transition. Hormone therapy is one of the few interventions with documented benefit here. The North American Menopause Society's 2022 position statement specifically names prevention of bone loss as one of hormone therapy's established benefits, alongside treating hot flashes and night sweats.

Bone loss doesn't announce itself. There's no ache that reliably shows up before a fracture does. That's exactly why it tends to fall out of the conversation. There's nothing prompting the question in the room unless someone raises it on purpose.

The Heart Side

Cardiovascular risk shifts during this window too and the American Heart Association addressed it directly in a scientific statement published in Circulation. Women who reach menopause before age 45 face meaningfully higher coronary heart disease risk than women who reach it later, a relative risk of 1.5, along with a higher risk of heart failure. The presence of hot flashes and night sweats themselves was associated with increased risk of coronary heart disease, stroke, or cardiovascular disease more broadly, even after accounting for standard risk factors.

The AHA statement identifies late perimenopause and early postmenopause specifically as a higher risk window. Cholesterol levels can rise measurably in the years surrounding your final period and abdominal fat tends to increase starting roughly 2 years before it, independent of ordinary aging. This is a distinct biological shift, not just the accumulation of another decade.

Where Hormone Therapy Fits Into This And Where It Doesn't

This is the same timing principle that governs hormone therapy's safety profile more broadly. Research reviewed in the AHA statement suggests starting hormone therapy before age 60 or within 10 years of menopause may reduce coronary heart disease risk by roughly half, compared to starting later, when initiation shows a neutral or even unfavorable effect. That's a meaningful number and also not a reason to assume hormone therapy is the right call for every woman's cardiovascular picture. It's a reason to have your actual risk factors reviewed as part of the decision, not left out of it.

Why Does This Get Left Out Of A Standard Visit?

Bone density and cardiovascular risk aren't things most women think to ask about at a menopause appointment because the appointment is usually booked over a symptom that's actively bothering them; a hot flash, a mood shift, or a sleepless night. A generalist visit built around symptom relief doesn't always leave room for a conversation about risks that won't show up for years. That's not negligence. It's a structural gap in what a short appointment has time to cover.

What To Actually Ask For

A useful menopause visit can include a conversation about baseline bone density testing and a cardiovascular risk review (cholesterol, blood pressure, family history), timed around the transition rather than left for a routine physical years later. Neither requires urgency or alarm. They require being on the agenda, the same way a hot flash or a sleep complaint would be.

What This Is And Isn't Meant To Do

None of this is meant to be alarming for its own sake. It's meant to close a gap. There are real, studied risks tied specifically to the menopause transition, and they deserve a place in the conversation alongside hot flashes and sleep. Not because something is necessarily wrong, but because a plan for your bones and your heart is as much a part of menopause care as a plan for your symptoms.

‍

Sources

American Heart Association — “Menopause Transition and Cardiovascular Disease Risk” Scientific Statement, Circulation (ahajournals.org)

The North American Menopause Society — 2022 Hormone Therapy Position Statement (menopause.org)

‍

You deserve care that actually listens. SAPIA Medical is a physician-led telehealth practice built for women navigating perimenopause, menopause, hormone therapy, and weight management. We started SAPIA because too many women leave appointments with more questions than answers — so our physicians take the time to understand your history and goals, then build a plan that's genuinely yours. No rushed visits. No guesswork. Just attentive care from a team that gets it.